GIAPREZA (angiotensin II acetate, human)
RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (RAAS) HORMONES · HYPOTENSION DUE TO DISTRIBUTIVE SHOCK
LA JOLLA PHARMA
Drug class
Renin-Angiotensin-Aldosterone System (RAAS) Hormones
"Renin-Angiotensin-Aldosterone System (RAAS) Hormones" is an administrative and formulary grouping rather than an established pharmacologic drug class. Read more about Renin-Angiotensin-Aldosterone System (RAAS) Hormones
2 drugs in this class 2 manufacturers
Drugs in Renin-Angiotensin-Aldosterone System (RAAS) Hormones
FILSPARI (sparsentan)
ANGIOTENSIN II RECEPTOR ANTAGONISTS (ARBS) · IMMUNOGLOBULIN A NEPHROPATHY ·+1
RETROPHIN, INC.
Filter & compare in the drug finder →
Opens the drug finder with Renin-Angiotensin-Aldosterone System (RAAS) Hormones preselected. Add indication or manufacturer filters there.
"Renin-Angiotensin-Aldosterone System (RAAS) Hormones" is an administrative and formulary grouping rather than an established pharmacologic drug class.
In therapeutic classification systems, this category represents exogenous, synthetic analogs of endogenous RAAS peptide hormones, specifically synthetic human angiotensin II.
These agents function as potent vasoconstrictors by directly stimulating vascular angiotensin II type 1 receptors and promoting aldosterone release, thereby elevating systemic vascular resistance and blood pressure.
Clinically, synthetic RAAS hormone therapy is approved for use in critical care medicine to treat hypotension in adults suffering from septic or other distributive shock.
-
wellfleetrx.com
"Renin-Angiotensin-Aldosterone System (RAAS) Hormones" is an administrative and formulary grouping rather than an established pharmacologic drug class
-
wikipedia.org
In therapeutic classification systems, this category represents exogenous, synthetic analogs of endogenous RAAS peptide hormones, specifically synthetic human angiotensin II
-
pharmacytimes.com
These agents function as potent vasoconstrictors by directly stimulating vascular angiotensin II type 1 receptors and promoting aldosterone release, thereby elevating systemic vascular resistance and blood pressure Clinically, synthetic RAAS hormone therapy is approved for use in critical care medicine to treat hypotension in adults suffering from septic or other distributive shock
-
nih.gov
These agents function as potent vasoconstrictors by directly stimulating vascular angiotensin II type 1 receptors and promoting aldosterone release, thereby elevating systemic vascular resistance and blood pressure
-
fda.gov
Clinically, synthetic RAAS hormone therapy is approved for use in critical care medicine to treat hypotension in adults suffering from septic or other distributive shock
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.